Genetic Variations in PRKAA1 Predict the Risk and Progression of Gastric Cancer.

Minbin Chen,Baohu Jiang,Bangshun He,Min Tang,Ping Wang,Li Chen,Jianwei Lu,Peihua Lu
DOI: https://doi.org/10.1186/s12885-018-4818-3
IF: 4.638
2018-01-01
BMC Cancer
Abstract:PRKAA1 encodes α-subunit of 5-AMP-activated protein kinase (AMPK), which has been implicated in the pathogenesis of carcinoma of the stomach. Previous works have suggested that polymorphisms in the PRKAA1 may be associated with the risk of non-cardiac gastric cancer (NCGC), but whether PRKAA1 polymorphisms are related to clinical pathologic characteristics of gastric cancer and its clinical outcome is largely unknown.
What problem does this paper attempt to address?